Collaborative science to advance gene therapies in resource-limited parts of the world.
作者信息
McCune Joseph M, Stevenson Susan C, Doehle Brian P, Trenor Cameron C, Turner Emily H, Spector Jonathan M
机构信息
HIV Frontiers, Global Health Innovative Technology Solutions Bill & Melinda Gates Foundation, Seattle, WA, USA.
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
出版信息
Mol Ther. 2021 Nov 3;29(11):3101-3102. doi: 10.1016/j.ymthe.2021.05.024. Epub 2021 Aug 30.
Abstract
摘要
相似文献
1
Collaborative science to advance gene therapies in resource-limited parts of the world.开展合作科研，推动在世界资源匮乏地区的基因治疗。
Mol Ther. 2021 Nov 3;29(11):3101-3102. doi: 10.1016/j.ymthe.2021.05.024. Epub 2021 Aug 30.
2
Compilation of online resources of relevance to 'Spinraza and advanced therapies: a stakeholder special' issue of Gene Therapy.与《基因治疗》“Spinraza与先进疗法：利益相关者特刊”相关的在线资源汇编
Gene Ther. 2017 Sep;24(9):599. doi: 10.1038/gt.2017.61.
3
Gene therapies advance, but some see manufacturing challenges.基因疗法取得进展，但一些人看到了制造方面的挑战。
Nat Med. 2012 Dec;18(12):1718-9. doi: 10.1038/nm1212-1718.
4
Make gene therapies more available by manufacturing them in lower-income nations.通过在低收入国家生产基因疗法，使其更易于获得。
Nature. 2024 Jul;631(8021):502-504. doi: 10.1038/d41586-024-02310-y.
5
Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network.资源有限环境下HIV耐药性对一线和二线治疗的影响：由HIV与抗HIV耐药性协作网络组织的研讨会报告
Antivir Ther. 2013;18(6):831-6. doi: 10.3851/IMP2650. Epub 2013 Jun 5.
6
Implementation science in resource-poor countries and communities.资源匮乏国家和社区中的实施科学。
Implement Sci. 2018 Dec 27;13(1):154. doi: 10.1186/s13012-018-0847-1.
7
Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines.资源有限国家的乳腺癌：《2005年全球乳腺癌防治倡议》指南概述
Breast J. 2006 Jan-Feb;12 Suppl 1:S3-15. doi: 10.1111/j.1075-122X.2006.00199.x.
8
Progress in Kidney Health in Low-Resource Settings: Building a More Equitable World-Introduction.
Semin Nephrol. 2022 Sep;42(5):151339. doi: 10.1016/j.semnephrol.2023.151339. Epub 2023 Mar 29.
9
Pediatric Emergency and Critical Care Resources and Infrastructure in Resource-Limited Settings: A Multicountry Survey.资源有限环境下儿科急诊和危重病资源与基础设施：一项多国家调查。
Crit Care Med. 2021 Apr 1;49(4):671-681. doi: 10.1097/CCM.0000000000004769.
10
Dependence on Digital Medicine in Resource-Limited Settings.资源有限环境下对数字医学的依赖。
Am J Bioeth. 2018 Sep;18(9):54-56. doi: 10.1080/15265161.2018.1498949.
引用本文的文献
1
How to democratize cell and gene therapy: A global approach.如何使细胞和基因疗法民主化：一种全球方法。
Mol Ther. 2025 May 7;33(5):2082-2090. doi: 10.1016/j.ymthe.2025.03.061. Epub 2025 Apr 2.
2
Balancing benefits and burdens: a systematic review on ethical and social dimensions of gene and cell therapies for hereditary blood diseases.权衡利弊：关于遗传性血液疾病基因和细胞疗法伦理与社会层面的系统评价
BMC Med Ethics. 2025 Mar 14;26(1):36. doi: 10.1186/s12910-025-01188-3.
3
Single-stranded DNA with internal base modifications mediates highly efficient knock-in in primary cells using CRISPR-Cas9.具有内部碱基修饰的单链DNA利用CRISPR-Cas9在原代细胞中介导高效的基因敲入。
Nucleic Acids Res. 2024 Dec 11;52(22):13561-13576. doi: 10.1093/nar/gkae1069.
4
Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?2024年病程记录：治愈艾滋病病毒；是我有生之年无法实现还是指日可待？
Pathog Immun. 2024 Mar 1;8(2):115-157. doi: 10.20411/pai.v8i2.665. eCollection 2023.
5
The long-term impact and value of curative therapy for HIV: a modelling analysis.长效治疗对 HIV 的长期影响和价值：建模分析。
J Int AIDS Soc. 2023 Sep;26(9):e26170. doi: 10.1002/jia2.26170.
6
Current challenges and new approaches to implementing optimal management of sickle cell disease in sub-Saharan Africa.撒哈拉以南非洲实施镰状细胞病最佳管理的当前挑战和新方法。
Semin Hematol. 2023 Sep;60(4):192-199. doi: 10.1053/j.seminhematol.2023.08.002. Epub 2023 Aug 24.
7
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission.制定改善镰状细胞病结局的全球战略：柳叶刀血液学委员会。
Lancet Haematol. 2023 Aug;10(8):e633-e686. doi: 10.1016/S2352-3026(23)00096-0. Epub 2023 Jul 11.
8
Ethical and practical considerations for cell and gene therapy toward an HIV cure: findings from a qualitative in-depth interview study in the United States.细胞和基因治疗实现 HIV 治愈的伦理与实践考量：来自美国深入定性访谈研究的发现。
BMC Med Ethics. 2022 Apr 9;23(1):39. doi: 10.1186/s12910-022-00780-1.
9
The genome-editing decade.基因组编辑的十年。
Mol Ther. 2021 Nov 3;29(11):3093-3094. doi: 10.1016/j.ymthe.2021.10.016. Epub 2021 Oct 26.
本文引用的文献
1
Multi-stakeholder consensus on a target product profile for an HIV cure.多方利益相关者对 HIV 治愈的目标产品特征达成共识。
Lancet HIV. 2021 Jan;8(1):e42-e50. doi: 10.1016/S2352-3018(20)30234-4. Epub 2020 Nov 30.
2
The case for an HIV cure and how to get there.实现 HIV 治愈的理由与路径
Lancet HIV. 2021 Jan;8(1):e51-e58. doi: 10.1016/S2352-3018(20)30232-0. Epub 2020 Nov 30.
3
Bringing Gene Therapies for HIV Disease to Resource-Limited Parts of the World.将针对艾滋病的基因疗法推广至世界资源匮乏地区。
Hum Gene Ther. 2021 Jan;32(1-2):21-30. doi: 10.1089/hum.2020.252. Epub 2020 Oct 30.
4
Treating sickle cell anemia.治疗镰状细胞贫血。
Science. 2020 Mar 13;367(6483):1198-1199. doi: 10.1126/science.aba3827.
5
Why and where an HIV cure is needed and how it might be achieved.为什么需要艾滋病治愈以及在何处需要艾滋病治愈，以及如何实现艾滋病治愈。
Nature. 2019 Dec;576(7787):397-405. doi: 10.1038/s41586-019-1841-8. Epub 2019 Dec 18.
6
Finding a cure for sickle cell disease.寻找镰状细胞病的治愈方法。
Nat Med. 2019 Dec;25(12):1811. doi: 10.1038/s41591-019-0691-0.
7
Gates and NIH join forces on HIV and sickle cell diseases.盖茨基金会与美国国立卫生研究院携手应对艾滋病和镰状细胞病。
Science. 2019 Nov 1;366(6465):558-559. doi: 10.1126/science.366.6465.558-b.
8
HIV "cure": A shot in the arm?HIV“治愈”：一针见效？
EBioMedicine. 2019 Apr;42:3-5. doi: 10.1016/j.ebiom.2019.04.011. Epub 2019 Apr 11.
9
Gene therapy for blood diseases.血液疾病的基因治疗。
Curr Opin Biotechnol. 2019 Dec;60:39-45. doi: 10.1016/j.copbio.2018.11.016. Epub 2018 Dec 29.
10
Gene therapy comes of age.基因治疗走向成熟。
Science. 2018 Jan 12;359(6372). doi: 10.1126/science.aan4672.
Zotero 插件